Announcement – Call for Scientific Papers
Dr. Abha Chauhan and Science Publications, New York, USA announce a Special Issue of The American Journal of Biochemistry and Biotechnology (ISSN: 15533468) on Autism Spectrum Disorders, to be published in 2007.
Topics in this issue include, but are not limited to:
- Oxidative stress in autism
- Immune abnormalities and inflammation in autism
- Genetic factors in autism
- Membrane abnormalities in autism
- Neuropathology of autism
- Mitochondrial dysfunction and abnormal energy metabolism in autism
- Environmental risk factors in autism
- Advances in the diagnosis of autism
- Intervention strategies in autism
GUIDELINES FOR AUTHORS
- In preparing the manuscript, authors should refer to the Instructions for American Journal of Biotechnology and Biotechnology on the website http://www.scipub.org/scipub/instructions.php?j_id=ajbb.
There will be no publication or page charges for this special issue on Autism Spectrum Disorders.
- Submission of a manuscript for this journal implies that it is not being submitted for publication elsewhere and that it does not infringe any existing copyright or any other third party rights.
- Please prepare manuscript as a PDF or in MS Word format and send to Dr. Abha Chauhan (firstname.lastname@example.org, email@example.com) by March 1, 2007.
- March 1, 2007: Submission deadline for manuscripts
- April 10, 2007: Reviewers’ comments will be sent to authors
- May 15, 2007: Submission deadline for revised manuscripts
Dr. Abha Chauhan
Department of Neurochemistry
NYS Institute for Basic Research in Developmental Disabilities
1050 Forest Hill Road
Staten Island, New York 10314, U.S.A.
Email: firstname.lastname@example.org, email@example.com
- Dr. Ved Chauhan, NYS Institute for Basic Research in Developmental Disabilities, Staten Island, NY
- Dr. George Perry, University of Texas at San Antonio, San Antonio, TX
Dr.Woody McGinnis, Ashland, OR
- Dr. David G. Amaral, M.I.N.D. Institute, University of California at Davis, Sacramento, CA
- Dr. Paul Ashwood, M.I.N.D. Institute, University of California at Davis, Sacramento, CA
- Dr. Joseph D. Buxbaum, Mount Sinai School of Medicine, New York, NY
- Dr. Sue T. Griffin, University of Arkansas for Medical Sciences, Little Rock, AR
- Dr. Martha R. Herbert, Harvard Medical School, Massachusetts General Hospital, Charlestown, MA
- Dr. William G. Johnson, UMDNJ-Robert Wood Johnson Medical School, Piscataway, NJ
- Dr. George H. Lambert, UMDNJ-Robert Wood Johnson Medical School, Piscataway, NJ
- Dr. Carlos A. Pardo, Johns Hopkins University School of Medicine, Baltimore, MD
- Dr. Sally J. Rogers, M.I.N.D. Institute, University of California at Davis Medical Center, Sacramento, CA
- Dr. Fred R. Volkmar, Yale Child Study Center, New Haven, CT
- Dr. Xiongwei Zhu, Case Western Reserve Univ., Cleveland, OH
Autistic people have fought the inclusion of ABA in therapy for us since before Autism Speaks, and other non-Autistic-led autism organizations, started lobbying legislation to get it covered by insurances and Medicaid.
ABA is a myth originally sold to parents that it would keep their Autistic child out of an institution. Today, parents are told that with early intervention therapy their child will either be less Autistic or no longer Autistic by elementary school, and can be mainstreamed in typical education classes. ABA is very expensive to pay out of pocket. Essentially, Autism Speaks has justified the big price tag up front will offset the overall burden on resources for an Autistic’s lifetime. The recommendation for this therapy is 40 hours a week for children and toddlers.
The original study that showed the success rate of ABA to be at 50% has never been replicated. In fact, the study of ABA by United States Department of Defense was denounced as a failure. Not just once, but multiple times. Simply stated: ABA doesn’t work. In study after repeated study: ABA (conversion therapy) doesn’t work.
What more recent studies do show: Autistics who experienced ABA therapy are at high risk to develop PTSD and other lifelong trauma-related conditions. Historically, the autism organizations promoting ABA as a cure or solution have silenced Autistic advocates’ opposition. ABA is also known as gay conversion therapy.
The ‘cure’ for Autistics not born yet is the prevention of birth.
The ‘cure’ is a choice to terminate a pregnancy based on ‘autism risk.’ The cure is abortion. This is the same ‘cure’ society has for Down Syndrome.
This is eugenics 2021. Instead of killing Autistics and disabled children in gas chambers or ‘mercy killings’ like in Aktion T4, it’ll happen at the doctor’s office, quietly, one Autistic baby at a time. Different approaches yes, but still eugenics and the extinction of an entire minority group of people.
Fact: You can’t cure Autistics from being Autistic.
Fact: You can’t recover an Autistic from being Autistic.
Fact: You can groom an Autistic to mask and hide their traits. Somewhat. … however, this comes at the expense of the Autistic child, promotes Autistic Burnout (this should not be confused with typical burnout, Autistic Burnout can kill Autistics), and places the Autistic child at high risk for PTSD and other lifelong trauma-related conditions.
[Note: Autism is NOT a disease, but a neurodevelopmental difference and disability.]
Fact: Vaccines Do Not Cause Autism.